Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Metabolic syndrome [[electronic resource] ] : underlying mechanisms and drug therapies / / edited by Minghan Wang
| Metabolic syndrome [[electronic resource] ] : underlying mechanisms and drug therapies / / edited by Minghan Wang |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2011 |
| Descrizione fisica | 1 online resource (510 p.) |
| Disciplina | 616.3/99 |
| Altri autori (Persone) | WangMinghan <1966-> |
| Soggetto topico |
Metabolic syndrome - Pathophysiology
Metabolic syndrome - Chemotherapy |
| ISBN |
0-470-92271-0
1-282-88898-6 9786612888984 0-470-91001-1 0-470-91000-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan Wang -- Central glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens -- Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau -- Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq ... [et al.] -- Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang -- Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang -- Mechanisms and complications of metabolic syndrome / Minghan Wang -- Emerging therapeutic approaches for dyslipidemia associated with high LDL and low HDL / Margrit Schwarz and Jae B. Kim -- Mechanism of action of niacin : implications for atherosclerosis and drug discovery / Devan Marar ... [et al.] -- Current anti-diabetic therapies and mechanisms / Minghan Wang -- GLP-1 biology, signaling mechanisms, physiology, and clinical studies / Remy Burcelin ... [et al.] -- Dipeptidyl peptidase IV inhibitors for treatment of diabetes / McIntosh, C.H.S. ... [et al.] -- Sodium glucose co-transporter 2 inhibitors / Margaret Ryan and Serge A. Jabbour -- Fibroblast growth factor 21 as a novel metabolic regulator / Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov -- Sirtuins as potential drug targets for metabolic diseases / Qiang Tong -- 11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes / Clarence Hale and David J. St. Jean, Jr -- Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade / Hai Yan, Wei Gu, and Murielle Veniant-Ellison -- Drug development for metabolic diseases: past, present and future / Minghan Wang. |
| Record Nr. | UNINA-9910140908703321 |
| Hoboken, N.J., : John Wiley & Sons, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metabolic syndrome [[electronic resource] ] : underlying mechanisms and drug therapies / / edited by Minghan Wang
| Metabolic syndrome [[electronic resource] ] : underlying mechanisms and drug therapies / / edited by Minghan Wang |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2011 |
| Descrizione fisica | 1 online resource (510 p.) |
| Disciplina | 616.3/99 |
| Altri autori (Persone) | WangMinghan <1966-> |
| Soggetto topico |
Metabolic syndrome - Pathophysiology
Metabolic syndrome - Chemotherapy |
| ISBN |
0-470-92271-0
1-282-88898-6 9786612888984 0-470-91001-1 0-470-91000-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan Wang -- Central glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens -- Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau -- Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq ... [et al.] -- Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang -- Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang -- Mechanisms and complications of metabolic syndrome / Minghan Wang -- Emerging therapeutic approaches for dyslipidemia associated with high LDL and low HDL / Margrit Schwarz and Jae B. Kim -- Mechanism of action of niacin : implications for atherosclerosis and drug discovery / Devan Marar ... [et al.] -- Current anti-diabetic therapies and mechanisms / Minghan Wang -- GLP-1 biology, signaling mechanisms, physiology, and clinical studies / Remy Burcelin ... [et al.] -- Dipeptidyl peptidase IV inhibitors for treatment of diabetes / McIntosh, C.H.S. ... [et al.] -- Sodium glucose co-transporter 2 inhibitors / Margaret Ryan and Serge A. Jabbour -- Fibroblast growth factor 21 as a novel metabolic regulator / Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov -- Sirtuins as potential drug targets for metabolic diseases / Qiang Tong -- 11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes / Clarence Hale and David J. St. Jean, Jr -- Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade / Hai Yan, Wei Gu, and Murielle Veniant-Ellison -- Drug development for metabolic diseases: past, present and future / Minghan Wang. |
| Record Nr. | UNINA-9910810084103321 |
| Hoboken, N.J., : John Wiley & Sons, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metabolic syndrome pathophysiology : the role of essential fatty acids / / Undurti N. Das
| Metabolic syndrome pathophysiology : the role of essential fatty acids / / Undurti N. Das |
| Autore | Das Undurti N |
| Pubbl/distr/stampa | Ames, Iowa, : Wiley-Blackwell, 2010 |
| Descrizione fisica | 1 online resource (284 p.) |
| Disciplina | 616.3/99 |
| Soggetto topico |
Metabolic syndrome - Pathophysiology
Essential fatty acids - Pathophysiology Unsaturated fatty acids - Pathophysiology Insulin resistance - Pathophysiology Non-insulin-dependent diabetes - Pathophysiology Brain - Metabolism |
| ISBN |
1-282-46162-1
9786612461620 0-8138-2063-4 0-8138-2071-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Metabolic Syndrome Pathophysiology : The Role of Essential Fatty Acids; Contents; Preface; 1 Introduction; 2 History, Definition, and Diagnosis of the Metabolic Syndrome; 3 Insulin Resistance in the Metabolic Syndrome; 4 Is It Necessary to Redefine the Metabolic Syndrome?; 5 Is Insulin Resistance a Disorder of the Brain?; 6 Obesity; 7 Perinatal Nutrition and Obesity; 8 Essential Hypertension; 9 Dietary Factors and Hypertension; 10 Is Hypertension a Disorder of the Brain?; 11 Type 2 Diabetes Mellitus; 12 Pathophysiology of Type 2 Diabetes Mellitus with Particular Reference to Hypothalamus
13 Insulin and Insulin Receptors in the Brain and Their Role in the Pathogenesis of Obesity and Type 2 Diabetes Mellitus14 Insulin, Endothelial Nitric Oxide, and the Metabolic Syndrome; 15 Obesity, Type 2 Diabetes Mellitus, the Metabolic Syndrome, and the Gut Microbiota; 16 Is It Possible That the Metabolic Syndrome Originates in the Perinatal Period?; 17 Essential Fatty Acids: Biochemistry and Physiology; 18 Role of EFAs/PUFAs in Brain Growth and Development and Pathophysiology of the Metabolic Syndrome; 19 EFAs/PUFAs and Their Metabolites in Insulin Resistance 20 EFAs/PUFAs and AtherosclerosisIndex |
| Record Nr. | UNINA-9910139504703321 |
Das Undurti N
|
||
| Ames, Iowa, : Wiley-Blackwell, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
